How a single synthetic steroid manages everything from asthma to rare kidney disease
In short: Budesonide is a versatile glucocorticoid that treats conditions as diverse as asthma, Crohn's disease, and IgA nephropathy. First patented in 1973, this synthetic steroid works by suppressing inflammation at the cellular level. Its unique delivery methods—from inhalers to rectal foams—allow it to target specific tissues while minimizing systemic side effects.
Budesonide is a non-halogenated cyclic ketal corticosteroid that functions as an agonist of glucocorticoid receptors. By depressing the migration of fibroblasts and polymorphonuclear leukocytes, it effectively reverses capillary permeability and stabilizes lysosomes to control inflammation. Because it is metabolized in the liver by the CYP3A4 enzyme, its pharmacokinetics vary significantly depending on the delivery method, with bioavailability ranging from as low as 3% in rectal foams to 39% via metered-dose inhalers.
The drug's clinical utility is broad. Beyond its long-term management of asthma and COPD, it is a preferred treatment for microscopic colitis and helps induce remission in ulcerative colitis. Recent applications include treating eosinophilic esophagitis via mouth-dispersing tablets and reducing proteinuria in patients with IgA nephropathy. During the COVID-19 pandemic, its role became a subject of intense global scrutiny; while UK and Indian health authorities recommended it for patients over 50 in 2021 following Oxford-led trials, the US NIH later withdrew its recommendation, citing a need for further research.
Despite its efficacy, budesonide requires careful management. Long-term use of oral forms can lead to adrenal insufficiency, and sudden cessation of therapy is dangerous. Furthermore, the drug is sensitive to metabolic interference; substances like grapefruit or medications that inhibit CYP3A4 can cause unwanted drug accumulation. Its history is also marked by controversy, including a 2019 lawsuit involving major pharmaceutical companies accused of conspiring to inflate the prices of generic drugs, including budesonide, by as much as tenfold.
While generally considered safe—even during pregnancy in its inhaled form—it is not without risks. Serious side effects include cataracts, bone density loss, and increased infection susceptibility. As a cornerstone of modern medicine, it remains on the World Health Organization's List of Essential Medicines, with over 3 million prescriptions recorded in the United States in 2023 alone.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Budesonide
To cite this card, link to https://intellectplus.co.uk/app/technology-budesonide.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Inventions · More in Technology · Latest · A–Z · All topics